Eli Lilly files first lawsuits over retatrutide 'black market'
Eli Lilly has sued six US companies for selling what it claims is the pharma giant’s investigational diabetes and weight loss drug retatrutide, which is still undergoing clinical trials. The litigation is Lilly’s first involving ...
We haven't written up this one. Endpoints News has the full story — the link below goes straight to it.
This story
This is one outlet's version. Read the fullest account.